Broadcast Date: April 20, 2021
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

The voyage of a cell or gene therapy from initial hypothesis to commercial delivery is complex and challenging. It requires a broad spectrum of scientific expertise, innovative technologies, and optimized processes to ensure these advanced therapeutics make it to market.

In this GEN webinar, our panelists—two industry leaders—will discuss what it takes to develop a cell or gene therapy from concept to commercialization, alongside a conversation about innovations that are likely to shape the future of advanced therapy discovery and biomanufacturing.

A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.


Webinar produced with support from:

Oxgene logo
David Chang, PhD
David Chang, PhD
Chief Executive Officer
WuXi Advanced Therapies
Ryan Cawood, PhD
Ryan Cawood, PhD
Managing Director, OXGENE
CSO, WuXi Advanced Therapies


The post Cell and Gene Therapies: From Concept to Commercialization appeared first on GEN – Genetic Engineering and Biotechnology News.